What to do if white blood cell count is low after chemotherapy for lung cancer

If leukopenia occurs after chemotherapy for lung cancer, we first need to understand the degree of bone marrow suppression and decide the treatment method based on the number of days after chemotherapy. If the first degree of bone marrow suppression occurs during the interval between chemotherapy, oral leukopenia drugs can be used. If the bone marrow suppression is second degree or above, leukopenia injections can be used. If severe bone marrow suppression occurs after the previous chemotherapy, long-acting leukopenia drugs can be used preventively after this chemotherapy. More importantly, drug intervention is also needed. If the patient's leukopenia is relatively low, leukopenia drugs must be used subcutaneously in time to restore the leukocytes as soon as possible in a short period of time. Otherwise, it is easy to develop secondary lung infections during the period of low leukopenia, leading to unnecessary problems.

What are the differences between lung tumors and lung cancer?

Malignant tumors of the lung include malignant lymphoma and malignant mesothelioma, which are characterized by rapid growth and can spread and metastasize throughout the body. Lung tumors include lung cancer, but tumors can be benign or malignant. Lung cancer is generally a malignant tumor. Lung tumors include benign and malignant tumors.

Can advanced lung cancer be cured?

The survival time of patients with advanced lung cancer who are positive for driver genes can reach about 2 years. Anti-tumor treatment measures such as chemotherapy, targeted therapy, and immunotherapy can effectively alleviate the clinical symptoms of advanced patients, reduce their pain, and improve their quality of life. The reason why lung cancer is so scary is mainly due to its high malignancy and easy metastasis and spread. In addition, most patients with advanced lung cancer are not suitable for surgical treatment and can only rely on chemotherapy and drugs for control. Lung cancer is roughly divided into small cell lung cancer and non-small cell lung cancer according to the different pathological types. Among them, non-small cell lung cancer is further divided into squamous cell carcinoma and adenocarcinoma. At present, the most progress in treatment is lung adenocarcinoma.